Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30899086 | 0.71 | TSHR (0.35) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL33525104 | 0.69 | ALDH1A1 (0.35) | TSHRALDH1A1 | |
| SCHEMBL34463892 | 0.67 | ALDH1A1 (0.44) | TSHRALDH1A1 | |
| Acrylic Acid Methyl Ester SCHEMBL1854813 | 0.62 | HCAR2 (0.56) | TSHRHPGDALDH1A1TP53HIF1A | |
| Acrylic Acid Methyl Ester SCHEMBL7645157 | 0.62 | HCAR2 (0.56) | TSHRHPGDALDH1A1TP53HIF1A | |
| Acrylic Acid Methyl Ester SCHEMBL9108 | 0.62 | — | — | |
| Cyclohexane SCHEMBL16179835 | 0.62 | HCAR2 (0.48) | TSHRHPGDALDH1A1TP53HIF1A | |
| Acrylic Acid Methyl Ester SCHEMBL29212937 | 0.62 | HCAR2 (0.48) | TSHRHPGDALDH1A1TP53HIF1A | |
| Acrylic Acid Methyl Ester SCHEMBL6915690 | 0.62 | HCAR2 (0.48) | TSHRHPGDALDH1A1TP53HIF1A | |
| Acrylic Acid Methyl Ester SCHEMBL8408215 | 0.62 | HCAR2 (0.48) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4729654-A2 | COMPOSITIONS FOR FORMING A CARBON DOPED SILICON CONTAINING FILM AND METHODS FOR FORMING SAID COMPOSITIONS AND METHODS AND SYSTEMS FOR USING SAID COMPOSITIONS | ASM IP Holding B.V. (NL) | 2026-04-22 | — | — | EP | claimed |
| US-20260092368-A1 | COMPOSITIONS FOR FORMING A CARBON DOPED SILICON CONTAINING FILM AND METHODS FOR FORMING SAID COMPOSITIONS AND METHODS AND SYSTEMS FOR USING SAID COMPOSITIONS | ASM IP HOLDING BV (NL) | 2026-04-02 | — | — | US | claimed |
| EP-4729654-A2 | COMPOSITIONS FOR FORMING A CARBON DOPED SILICON CONTAINING FILM AND METHODS FOR FORMING SAID COMPOSITIONS AND METHODS AND SYSTEMS FOR USING SAID COMPOSITIONS | ASM IP Holding B.V. (NL) | 2026-04-22 | — | — | EP | disclosed |
| US-20260092368-A1 | COMPOSITIONS FOR FORMING A CARBON DOPED SILICON CONTAINING FILM AND METHODS FOR FORMING SAID COMPOSITIONS AND METHODS AND SYSTEMS FOR USING SAID COMPOSITIONS | ASM IP HOLDING BV (NL) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260092368-A1 | COMPOSITIONS FOR FORMING A CARBON DOPED SILICON CONTAINING FILM AND METHODS FOR FORMING SAID COMPOSITIONS AND METHODS AND SYSTEMS FOR USING SAID COMPOSITIONS | SGMS1, PYM1, SGMS2 | TSHR 4558/4885HPGD 4616/4885ALDH1A1 2915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.